The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population

H. M. Westgeest*, M. C.P. Kuppen, A. J.M. van den Eertwegh, R. de Wit, A. M. Bergman, R. J.A. van Moorselaar, J. L.L.M. Coenen, A. C.M. van den Bergh, D. M. Somford, N. Mehra, I. M. van Oort, K. K.H. Aben, W. R. Gerritsen, C. A. Uyl-de Groot

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
101 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Agricultural and Biological Sciences